196 related articles for article (PubMed ID: 19843880)
21. Neuropathy in multiple myeloma treated with thalidomide: a prospective study.
Plasmati R; Pastorelli F; Cavo M; Petracci E; Zamagni E; Tosi P; Cangini D; Tacchetti P; Salvi F; Bartolomei I; Michelucci R; Tassinari CA
Neurology; 2007 Aug; 69(6):573-81. PubMed ID: 17679676
[TBL] [Abstract][Full Text] [Related]
22. Thalidomide and lenalidomide in the treatment of multiple myeloma.
Kumar S; Rajkumar SV
Eur J Cancer; 2006 Jul; 42(11):1612-22. PubMed ID: 16750621
[TBL] [Abstract][Full Text] [Related]
23. Primary treatment with pulsed melphalan, dexamethasone and thalidomide for elderly symptomatic patients with multiple myeloma.
Dimopoulos MA; Anagnostopoulos A; Terpos E; Repoussis P; Zomas A; Katodritou E; Kyrtsonis MC; Delibasi S; Vassou A; Pouli A; Zervas K; Anagnostopoulos N; Maniatis A;
Haematologica; 2006 Feb; 91(2):252-4. PubMed ID: 16461313
[TBL] [Abstract][Full Text] [Related]
24. Lenalidomide: a new agent for patients with relapsed or refractory multiple myeloma.
Tariman JD
Clin J Oncol Nurs; 2007 Aug; 11(4):569-74. PubMed ID: 17723971
[TBL] [Abstract][Full Text] [Related]
25. [Thalidomide. Clinical trials in cancer].
Politi PM
Medicina (B Aires); 2000; 60 Suppl 2():61-5. PubMed ID: 11188934
[TBL] [Abstract][Full Text] [Related]
26. [Thalidomide with or without dexamethasone for refractory multiple myeloma].
Boulin M; Blanchet F; Isambert N; Solary E; Solier S; Collin B; Pernot C; Durnet-Archeray MJ
Therapie; 2002; 57(6):524-9. PubMed ID: 12666259
[TBL] [Abstract][Full Text] [Related]
27. Thalidomide: new indication. For elderly myeloma patients: some improvement in first-line treatment.
Prescrire Int; 2009 Apr; 18(100):49-52. PubMed ID: 19585712
[TBL] [Abstract][Full Text] [Related]
28. [New treatment strategy of multiple myeloma for cure].
Murakami H; Handa H
Gan To Kagaku Ryoho; 2006 Apr; 33(4):417-23. PubMed ID: 16612147
[TBL] [Abstract][Full Text] [Related]
29. Thalidomide-based treatment for HIV-associated multiple myeloma: a case report.
Aboulafia DM
AIDS Read; 2003 Aug; 13(8):383-9. PubMed ID: 14524324
[TBL] [Abstract][Full Text] [Related]
30. Current status of thalidomide in the treatment of cancer.
Rajkumar SV
Oncology (Williston Park); 2001 Jul; 15(7):867-74; discussion 877-9. PubMed ID: 11499688
[TBL] [Abstract][Full Text] [Related]
31. [Therapeutic effectiveness of thalidomide to multiple myeloma and its mechanism].
Wang M; Liu Y; Li Y; Wu H
Zhonghua Xue Ye Xue Za Zhi; 2002 Oct; 23(10):514-6. PubMed ID: 12482346
[TBL] [Abstract][Full Text] [Related]
32. Thalidomide in multiple myeloma--clinical trials and aspects of drug metabolism and toxicity.
Breitkreutz I; Anderson KC
Expert Opin Drug Metab Toxicol; 2008 Jul; 4(7):973-85. PubMed ID: 18624684
[TBL] [Abstract][Full Text] [Related]
33. [New indications for thalidomide?].
Tuinmann G; Hegewisch-Becker S; Hossfeld DK
Dtsch Med Wochenschr; 2001 Oct; 126(42):1178-82. PubMed ID: 11607859
[No Abstract] [Full Text] [Related]
34. [Retrospective analysis of thalidomide therapy in patients with relapsed/refractory multiple myeloma].
Ikebe T; Ogata M; Miyazaki M; Miyazaki Y; Ohtsuka E; Saburi Y; Goto K; Ikewaki J; Kohno K; Uno N; Imamura T; Akagi T; Kadota J
Rinsho Ketsueki; 2010 Feb; 51(2):114-21. PubMed ID: 20379102
[TBL] [Abstract][Full Text] [Related]
35. Thalidomide-dexamethasone versus interferon-alpha-dexamethasone as maintenance treatment after ThaDD induction for multiple myeloma: a prospective, multicentre, randomised study.
Offidani M; Corvatta L; Polloni C; Piersantelli MN; Gentili S; Galieni P; Visani G; Alesiani F; Catarini M; Brunori M; Samori A; Burattini M; Centurioni R; Ferranti M; Giuliodori L; Candela M; Mele A; Marconi M; Leoni P
Br J Haematol; 2009 Mar; 144(5):653-9. PubMed ID: 19036082
[TBL] [Abstract][Full Text] [Related]
36. [How I treat... refractory multiple myeloma with thalidomide].
Scerbo F; Matus G; Sautois B; Fillet G
Rev Med Liege; 2000 Nov; 55(11):970-3. PubMed ID: 11195707
[TBL] [Abstract][Full Text] [Related]
37. Thalidomide in cancer medicine.
Eleutherakis-Papaiakovou V; Bamias A; Dimopoulos MA
Ann Oncol; 2004 Aug; 15(8):1151-60. PubMed ID: 15277253
[TBL] [Abstract][Full Text] [Related]
38. Thalidomide: current therapeutic uses and management of its toxicities.
Tariman JD
Clin J Oncol Nurs; 2003; 7(2):143-7. PubMed ID: 12696209
[TBL] [Abstract][Full Text] [Related]
39. Thalidomide. A new beginning.
Valorie AM
Cancer Pract; 2000; 8(2):101-3. PubMed ID: 11898173
[No Abstract] [Full Text] [Related]
40. [Thalidomide: the revival].
Grosbois B; Duguet C
Rev Med Interne; 2001 Jan; 22(1):5-7. PubMed ID: 11218298
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
